Minimally invasive surgery for inflammatory bowel disease.

Area of Science:

• Gastroenterology
• Surgical Innovation
• Inflammatory Bowel Disease Management

Background:

• Surgical management of IBD presents challenges due to complications like fistulas, abscesses, and complex postoperative anatomy.
• Patients with Crohn's disease and ulcerative colitis often have comorbidities (anemia, malnutrition, immunosuppression) increasing surgical risks.
• Traditional open surgery for IBD carries significant short- and long-term patient burdens.

Purpose of the Study:

• To review the current state-of-the-art in minimally invasive surgery (MIS) for inflammatory bowel disease (IBD).
• To discuss the inherent challenges and caveats of applying MIS in complex IBD patients.
• To explore current and future trends in MIS techniques for IBD, including laparoscopic, single-incision, and robotic-assisted surgery.

Main Methods:

• Review of current literature and clinical experience with MIS for IBD.
• Analysis of patient benefits associated with laparoscopic versus open surgical approaches.
• Examination of emerging MIS techniques and their applicability to IBD.

Main Results:

• Minimally invasive surgery has become the standard of care for IBD, offering significant short- and long-term patient benefits over open surgery.
• Technological advancements have enabled laparoscopic management, reducing physical trauma and morbidity.
• Various MIS techniques, including single-incision laparoscopic surgery (SILS) and robotic-assisted surgery, are being explored for IBD.

Conclusions:

• Minimally invasive surgery significantly decreases the short- and long-term burden of surgery for chronic IBD.
• MIS represents high-value care for both patients and society in the context of inflammatory bowel disease.
• Continued innovation in MIS techniques promises further improvements in surgical outcomes for IBD patients.